Deutsch English Français

Contact

EP2350060

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2350060

EP2350060 - MELANOCORTIN RECEPTOR AGONISTS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 25.07.2014 Database last updated on 15.06.2024
Most recent event Tooltip	04.09.2015	Lapse of the patent in a contracting state New state(s): MT	published on 07.10.2015 [2015/41]
Applicant(s)	For all designated states LG Life Sciences Ltd LG Twin Tower, East Tower 20, Yoido-dong Youngdungpo-ku Seoul 150-010 / KR
	[2011/31]
Inventor(s)	01 / LEE, Koo R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	02 / LEE, Sang Dae R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	03 / MOON, Sang Pil R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	04 / AHN, In Ae R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	05 / CHOI, Sung Pil R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	06 / LEE, Hyun Ho R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	07 / SHIM, Dong Sup R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	08 / CHUNG, Soo Yong R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	09 / LEE, Hyun Min R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	[2013/38]
Former [2011/31]	01 / LEE, Koo R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	02 / LEE, Sang Dae R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	03 / MOON, Sang Pil R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	04 / AHN, In Ae R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	05 / CHOI, Sung Pil R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	06 / LEE, Hyun Ho R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	07 / SHIM, Dong Sup R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	08 / CHUNG, Soo Yong R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
	09 / LEE, Hyun Min R&D Park LG Life Sciences Ltd. 104-1 Moongi-dong Yuseong-gu Daejeon 305-380 / KR
Representative(s)	Busher, Samantha Jane, et al Elkington and Fife LLP 3-4 Holborn Circus London, EC1N 2HA / GB
	[2014/27]
Former [2013/38]	Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
Former [2011/31]	Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
Application number, filing date	09826254.6	10.11.2009
	[2011/31]
	WO2009KR06568
Priority number, date	KR20080112403	12.11.2008 Original published format: KR 20080112403
	[2011/31]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2010056022
	Date:	20.05.2010
	Language:	EN
	[2010/20]
	Type:	A2 Application without search report
	No.:	EP2350060
	Date:	03.08.2011
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.05.2010 takes the place of the publication of the European patent application.
	[2011/31]
	Type:	B1 Patent specification
	No.:	EP2350060
	Date:	18.09.2013
	Language:	EN
	[2013/38]
Search report(s)	International search report - published on:	KR	10.09.2010
	(Supplementary) European search report - dispatched on:	EP	22.06.2012
Classification	IPC:	C07D403/14, C07D401/14, C07D403/06, C07D405/14, C07D409/14, A61K31/4025, A61P3/04, A61P3/10, A61P15/10, A61P29/00	[2012/30]
	CPC:	C07D417/14 (EP,US); C07D403/14 (KR); A61K31/4025 (EP,KR,US); A61K31/496 (EP,US); A61P15/00 (EP); A61P15/10 (EP); (+) A61P27/06 (EP); A61P29/00 (EP); A61P3/04 (EP); A61P3/10 (EP); A61P37/00 (EP); A61P43/00 (EP); C07D207/16 (EP,US); C07D401/14 (EP,KR,US); C07D403/06 (EP,US); C07D405/14 (EP,US); C07D409/14 (EP,US) (-)
	Former IPC [2011/31]	C07D403/14
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/31]
Extension states	AL	Not yet paid
	BA	Not yet paid
	RS	Not yet paid
Title	German:	MELANOCORTIN-REZEPTOR-AGONISTEN	[2011/31]
	English:	MELANOCORTIN RECEPTOR AGONISTS	[2011/31]
	French:	ANTAGONISTES DE RÉCEPTEUR DE MÉLANOCORTINE	[2011/31]
Entry into regional phase	06.05.2011	National basic fee paid
	06.05.2011	Search fee paid
	06.05.2011	Designation fee(s) paid
	06.05.2011	Examination fee paid
Examination procedure	01.06.2010	Request for preliminary examination filed International Preliminary Examining Authority: KR
	06.05.2011	Examination requested [2011/31]
	21.01.2013	Amendment by applicant (claims and/or description)
	27.03.2013	Communication of intention to grant the patent
	06.08.2013	Fee for grant paid
	06.08.2013	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.03.2013
Opposition(s)	19.06.2014	No opposition filed within time limit [2014/35]
Fees paid	Renewal fee
	14.11.2011	Renewal fee patent year 03
	13.11.2012	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	10.11.2009
	AT	18.09.2013
	BE	18.09.2013
	BG	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	MK	18.09.2013
	MT	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	RO	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	SM	18.09.2013
	IE	10.11.2013
	LU	10.11.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
	[2015/41]
Former [2015/34]	HU	10.11.2009
	AT	18.09.2013
	BE	18.09.2013
	BG	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	MK	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	RO	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	SM	18.09.2013
	IE	10.11.2013
	LU	10.11.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2015/32]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	MK	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	RO	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	SM	18.09.2013
	IE	10.11.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2015/24]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	RO	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	SM	18.09.2013
	IE	10.11.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2015/23]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	RO	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	IE	10.11.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/48]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	IE	10.11.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/41]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	DK	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/38]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	IT	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/34]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	CH	30.11.2013
	LI	30.11.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/33]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	MC	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/28]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
	PT	20.01.2014
Former [2014/24]	AT	18.09.2013
	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	EE	18.09.2013
	ES	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	NL	18.09.2013
	PL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
Former [2014/23]	BE	18.09.2013
	CY	18.09.2013
	CZ	18.09.2013
	EE	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	NL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	SK	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
	IS	18.01.2014
Former [2014/22]	BE	18.09.2013
	CY	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	NL	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
Former [2014/18]	BE	18.09.2013
	CY	18.09.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
Former [2014/12]	CY	26.06.2013
	FI	18.09.2013
	HR	18.09.2013
	LT	18.09.2013
	LV	18.09.2013
	SE	18.09.2013
	SI	18.09.2013
	NO	18.12.2013
	GR	19.12.2013
Former [2014/10]	CY	26.06.2013
	HR	18.09.2013
	LT	18.09.2013
	SE	18.09.2013
	NO	18.12.2013
Former [2014/09]	HR	18.09.2013
	LT	18.09.2013
	SE	18.09.2013
	NO	18.12.2013
Former [2014/08]	LT	18.09.2013
	NO	18.12.2013
Former [2014/07]	NO	18.12.2013
Documents cited:	Search	[YD]WO2005047251 (LG LIFE SCIENCES LTD [KR], et al) [YD] 1-15* examples 7-186,190-293; claim - *;
		[YD]WO2008007930 (LG LIFE SCIENCES LTD [KR], et al) [YD] 1-15 * examples A8,A55,A86,A93-A96; table 18 *
	International search	[A]US6534503 (DINES KEVIN C [US], et al);
		[A]US2003236262 (BAKSHI RAMAN K [US], et al);
		[A]US2004019094 (LUNDSTEDT TORBJORN [SE], et al);
		[A]US2007129346 (LEE KOO [KR], et al);
		[A] - HERPIN, TIMOTHY F. ET AL., "Discovery of Tyrosine-Based Potent and Selective Melanocortin-1 Receptor Small-Molecule Agonists with Anti-inflammatory Properties", J. MED. CHEM., (2003), vol. 46, pages 1123 - 1126, XP001182772 DOI: http://dx.doi.org/10.1021/jm025600i
	by applicant	WO0155109
		WO0170337
		WO0170708
		WO0215909
		WO0218327
		WO02059095
		WO02059107
		WO02059117
		WO02059108
		WO02067869
		WO02068387
		WO02068388
		WO02081443
		WO02085925
		WO03009847
		WO03009850
		WO2004078716
		WO2004078717
		WO2004087159
		WO2005040109
		WO2005047251
		WO2005077935
		WO2006019787
		WO2006020277
		WO2006072393
		WO2007015157
		WO2007015162
		WO2007041052
		WO2007041061
		WO2007047496
		JP2007131570
		WO2007096186
		WO2007096763
		WO2007141343
		WO2008007930
		WO2008039418
		- J. MED. CHEM., (2002), vol. 45, page 4589
		- BIOORG. MED. CHEM. LETT., (2005), vol. 15, page 171
		- BIOORG. MED. CHEM. LETT., (2005), vol. 15, page 3430
		- BIOORG. MED. CHEM. LETT., (2005), vol. 15, page 350 1
		- J MED CHEM, (2003), vol. 46, page 1123

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p